| Estrone-3-Glucuronide |
|
This assay was originally developed for the
World Health Organization as a non-invasive monitor of ovarian
function. It has been widely used in clinical trials and in the
assessment of natural family planning methods.
|
 |
| Method |
|
Urine samples are diluted in buffer and the
Estrone-3-Glucuronide concentration measured by EIA (enzyme
labelled immunoassay with magnetic second antibody separation).
All samples, standards and quality control specimens are assayed
in duplicate.
|
 |
| Quality Control |
|
Assays are controlled through the use of at
least 2 Internal Quality Control samples in every run. In addition
the performance of every run is closely monitored for various
parameters including imprecision, antibody binding of tracer,
non-specific binding and reproducibility of the standard curve.
- Standard Curve: The range of the standard curve is 0 to
10.7 nmol/L.
- Precision: The between-run precision of the assay is
generally less than 10% CV.
- Sensitivity: The sensitivity of the assay is
approximately 0.1 nmol/L (defined as 2 standard deviations in the
measurement of zero dose).
|
 |
| Specificity |
|
The cross-reactions of the
Estrone-3-Glucuronide antibody (estimated as the relative potency
causing a 50% displacement of zero binding) are shown below:
| Substance |
% Cross Reaction |
| Estrone-3-Glucuronide |
100 |
| Estrone |
97 |
| Estrone-3-Sulphate |
231 |
|
For more information and prices please contact us.
|